JAZZ News and Press, Jazz Pharmaceuticals plc From 05/20/21

Investments In The Top Marijuana Stocks In 2021 Are you looking for investment opportunities in top marijuana stocks right now? Recent market declines have made the best cannabis stocks to invest in much more attractive to traders. So far this year most leading cannabis companies are re...

NetworkNewsWire Editorial Coverage : Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks at substances such as psilocybin, ketamine, DMT (dimethyltryptamine),...

Jazz to Present New Data at ASCO and EHA 2021 Meetings Showcasing Clinical Advances Across Hematology and Oncology Portfolio Findings continue to demonstrate Jazz's leadership in developing treatments for difficult-to-treat conditions where few options exist PR Newswire ...

Yesterday, Jazz Pharmaceuticals (JAZZ) filed a complaint in Delaware federal court against Avadel Pharmaceuticals (AVDL) regarding an alleged infringement of five patents linked to the company’s blockbuster therapy Xyrem.The FDA application sought by Avadel to market its narcolepsy dru...

This neurobiology specialist just completed the acquisition of GW Pharma and this bolsters their pipeline diversity and strength. Xywav is set up to pick up the majority of the ending Xyrem revenues and maintain the company's forward momentum. The fundamental question will be whet...

Sam Zell's Equity Commonwealth (EQC) wins bidding war for Monmouth Real Estate Investment Corporation (MNR) but arbitrageurs are expecting more. Farm Bureau Property & Casualty Insurance Company bumps up its offer price for FBL Financial Group (FFG) to $61 per share from its previ...

Jazz Pharmaceuticals (NASDAQ: JAZZ) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. This brings the $7.6 billion cash-and-stock deal , first announced in early February, to a cl...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) closed on its acquisition of GW Pharmaceuticals and announced financial results for the first quarter of 2021 and affirmed financial guidance for 2021. On February 3, 2021 , the company said it planned to buy GW Pharmaceuticals for $2...

Jazz Pharmaceuticals (JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (GWPH).GW shareholders gave the thumbs up to the deal last month.With the acquisition, Jazz gains access to GW's cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 202...

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc PR Newswire DUBLIN , May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a lea...